Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

NCT00797953 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tasly Pharmaceuticals, Inc.